November 5, 2025 — Adagio Medical Holdings, Inc. (Nasdaq: ADGM) will present at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 10:30 a.m. ET at the Lotte Palace in New York, NY.
A live and recorded webcast of the presentation will be available at: https://event.webcasts.com/starthere.jsp?ei=1742138&tp_key=f2a06e9abc
Adagio is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation (ULTC) technology. The Company is currently focused on the treatment of ventricular arrhythmias with its purpose-built vCLAS™ Cryoablation System, which is CE Marked and is currently under evaluation in the Company’s FULCRUM-VT U.S. IDE Pivotal Study.
Source: Adagio Medical Holdings, Inc.: Source: Adagio Medical Holdings, Inc.
